Cephalalgia

Article	Citations
Chronic Migraine Epidemiology and Outcomes – International (CaMEO-I) Study: Methods and multi-country baseline findings for diagnosis rates and care	109
Harassment in the headache field: a global web-based cross-sectional survey	86
International Classification of Headache Disorders-4 – Work in Progress 1	75
A reply, drug-induced reversible cerebral vasoconstriction syndrome: Lessons from the real world	75
Fremanezumab for the Preventive Treatment of Migraine: Subgroup Analysis by Number of Prior Preventive Treatments with Inadequate Response	67
High perceived isolation and reduced social support affect headache impact levels in migraine after the Covid-19 outbreak: A cross sectional survey on chronic and episodic patients	61
Evaluating the efficacy of CGRP mAbs and gepants for the preventive treatment of migraine: A systematic review and network meta-analysis of phase 3 randomised controlled trials	60
Efficacy and tolerability of combination treatment of topiramate and greater occipital nerve block versus topiramate monotherapy for the preventive treatment of chronic migraine: A randomized controll	59
Evidence-based guidelines for the pharmacological treatment of migraine	56
Population-based prevalence of cranial autonomic symptoms in migraine and proposed diagnostic appendix criteria	54
Depression screening in migraine - A double-edged sword	53
Assessing migraine therapeutics	50
Genome-wide DNA methylation analysis in an antimigraine-treated preclinical model of cortical spreading depolarization	48
Comment on “What predicts citation counts and translational impact in headache research? A machine learning analysis”	43
Call for papers	42
Corrigendum to: Evaluation of outcomes of calcitonin gene-related peptide (CGRP)-targeting therapies for acute and preventive migraine treatment based on patient sex	41
Systemic lupus erythematosus mimicking retinal migraine: a case report	39
Diagnosis of idiopathic intracranial hypertension - the importance of excluding secondary causes: A systematic review	39
The effects of certain TRP channels and voltage-gated KCNQ/Kv7 channel opener retigabine on calcitonin gene-related peptide release in the trigeminovascular system	38
Guidelines of the International Headache Society for controlled trials of pharmacological preventive treatment for persistent post-traumatic headache attributed to mild traumatic brain injury	37
Letter to the editor regarding “Safety profile of erenumab, galcanezumab and fremanezumab in pregnancy and lactation: Analysis of the WHO pharmacovigilance database”	35
An altered reward system characterizes chronic migraine with medication overuse headache	34
Pain sensitivities predict prophylactic treatment outcomes of flunarizine in chronic migraine patients: A prospective study	32
Childhood and adolescent headache: A problem not to be ignored in the era of new therapies	31
Paroxysmal hemicrania and hemicrania continua: Review on pathophysiology, clinical features and treatment	30

Triptan non-response in a London tertiary headache centre: What can we learn? A retrospective study	30
CGRP-antibodies, topiramate and botulinum toxin type A in episodic and chronic migraine: A systematic review and meta-analysis	29
Effect of Altmetric score on manuscript citations: A randomized-controlled trial	28
COVID-19 vaccination-triggered cluster headache episodes with frequent attacks	27
Case reports: Could sexual dysfunction in women with migraine be a side effect of CGRP inhibition?	27
Galcanezumab modulates Capsaicin-induced C-fiber reactivity	27
History of maternal migraine and its association with preeclampsia: A case–control study in a low-resource setting in Sudan, Africa	27
What is the evolutionary disadvantage of migraine?	27
Real-world efficacy of galcanezumab for the treatment of migraine in Korean patients	27
Migraine and risk of atrial fibrillation: A 9-year follow-up based on the Trøndelag Health Study	26
Effect of COVID vaccination on monthly migraine days: a longitudinal cohort study	26
Sensitivity of the SNNOOP10 list in the high-risk secondary headache detection	26
Immunogenicity of erenumab: A pooled analysis of six placebo-controlled trials with long-term extensions	25
Physical impairment during and between migraine attacks: A daily diary study of patients with chronic migraine	25
Long-term open-label and real-world studies of lasmiditan, ubrogepant, and rimegepant for the acute treatment of migraine attacks	24
Guidelines of the International Headache Society for Clinic-Based Headache Registries, 1st edition	24
A placebo-controlled, randomized, single and multiple dose study to evaluate the safety, tolerability, and pharmacokinetics of rimegepant in healthy participants	24
The midfacial segment pain: little known disorder in need of scientific evaluation	23
Author response to ‘Clarification on the incidence and sex-specificity of sexual dysfunction as an adverse event of CGRP-targeting medications’	23
Sex differences in photophobic behaviors following cortical spreading depression in rats	23
Comorbidity or combination – more evidence for cluster-migraine?	23
Guidelines Update: Guidelines of the International Headache Society for controlled trials of preventive treatment of migraine in children and adolescents, 1st edition – An experience-based update	22
The non-decussating and decussating trigeminothalamic tracts in humans: A combination of connectome-based tractography and histological validation	22
Looking at Cephalalgia from the inside	22
Safety profile of monoclonal antibodies targeting the calcitonin gene-related peptide system in pregnancy: Updated analysis in VigiBase®	22
Crossing the Rubicon? The future impact of artificial intelligence on headache medicine	22
Clinical, oculographic, and vestibular test characteristics of vestibular migraine	21
Involvement of adenosine signaling pathway in migraine pathophysiology: A systematic review of clinical studies	21
Salivary CGRP can monitor the different migraine phases: CGRP (in)dependent attacks	21
Critique of the analysis of the time course for the antimigraine effect of ubrogepant 50 mg. Clinical relevance versus statistical significance	20
Alopecia as an emerging adverse event to CGRP monoclonal antibodies: Cases Series, evaluation of FAERS, and literature review	19
Muscae volitantes: A 19th-century precursor of visual snow syndrome?	19
The “index vein” as a sign for migraine aura in the emergency setting	19
Abstracts from the International Headache Congress 14–17 September 2023	18
Worldwide availability of medications for migraine and tension-type headache: A survey of the International Headache Society	17
Migraine-attributed burden, impact and disability, and migraine-impacted quality of life: Expert consensus on definitions from a Delphi process	17
Poor social support and loneliness in chronic headache: Prevalence and effect modifiers	17
Burden of headache in a HIV-positive population of sub-Saharan Africa	17
Abnormal heart rate variability and its application in predicting treatment efficacy in patients with chronic migraine: An exploratory study	17
Psychophysical testing in chronic migraine and chronic tension type headache: An observational study	17
Thanks to Reviewers	17
Are we closer to achieving precision medicine for migraine treatment? A narrative review	16
Erratum	16
Efficacy and safety of monoclonal antibodies targeting CGRP in migraine prevention. GRADE tables elaborated by the ad hoc working group of the International Headache Society	16
Premonitory symptoms in migraine: A REFORM Study	16
Efficacy of eptinezumab in non-responders to subcutaneous monoclonal antibodies against CGRP and the CGRP receptor: A retrospective cohort study	16
Two-year, real-world erenumab persistence and quality of life data in 82 pooled patients with abrupt onset, unremitting, treatment refractory headache and a migraine phenotype: New daily persistent he	16
Exploring the association between familial hemiplegic migraine genes (CACNA1A, ATP1A2 and SCN1A) with migraine and epilepsy: A UK Biobank exome-wide association study	16
The impact of eating disorders on idiopathic intracranial hypertension	16
Letter to the Editor regarding “Effect of Altmetric score on manuscript citations: A randomized-controlled trial”	16

Stroke due to small-vessel disease and migraine: A case–control study of a young adult with ischemic stroke population	16
Effectiveness of anti-CGRP monoclonal antibodies and onabotulinumtoxinA in menstrually-related migraine: The unmet need of perimenstrual headache days	15
Corneal confocal microscopy identifies corneal nerve fiber loss in patients with migraine	15
Internet and social media's role in migraine education: Headache or not headache?	15
Shared genetics and causal relationships between migraine and thyroid function traits	15
Guidelines of the International Headache Society for Controlled Clinical Trials in Cluster Headache	15
Neurological and psychiatric comorbidities of migraine: Concepts and future perspectives	15
Dose selection for fremanezumab (AJOVY) phase 3 pediatric migraine studies using pharmacokinetic data from a pediatric phase 1 study and a population pharmacokinetic modeling and simulation approach	15
Post-COVID-19 persistent headache: A multicentric 9-months follow-up study of 905 patients	15
Are the ICHD-3 criteria for headache attributed to idiopathic intracranial hypertension valid? Headache phenotyping and field-testing in newly diagnosed idiopathic intracranial hypertension	15
Cigarette smoking history (personal and secondary childhood exposure) in non-cluster headache trigeminal autonomic cephalalgias: A clinic based study	14
Board Walk – April 2022	14
New migraine drugs: A critical appraisal of the reason why the majority of migraine patients do not receive an adequate medication	14
Postprandial fasting related headache during Ramadan in Saudi Arabia: A cross-sectional study	14
The long-term effect of work schedule, shift work disorder, insomnia and restless legs syndrome on headache among nurses: A prospective longitudinal cohort study	14
Headache at the chronic stage of cerebral venous thrombosis	14
Corrigendum: No structural brain alterations in new daily persistent headache – a cross sectional VBM/SBM study	14
BoNT-A efficacy in high frequency migraine: an open label, single arm, exploratory study applying the PREEMPT paradigm	14
Recurrent Painful Ophthalmoplegic Neuropathy: A case report with atypical features and a review of the literature	14
Children under 6 years with acute headache in Pediatric Emergency Departments. A 2-year retrospective exploratory multicenter Italian study	13
Reply to “Methodological considerations in assessing the impact of CGRP monoclonal antibodies on blood pressure”	13
Comparison of continuous headache features in youth with migraine, new daily persistent headache, and persistent post-traumatic headache	13
Longitudinal trajectories of posttraumatic headache after pediatric mild traumatic brain injury	13
Switching anti-CGRP(R) monoclonal antibodies in multi-assessed non-responder patients and implications for ineffectiveness criteria: A retrospective cohort study	13
Avoidance behaviour modulates but does not condition phonophobia in migraine	13
Comment on “Lack of reproducibility of resting-state functional MRI findings in migraine with aura”	13
“Wearing-off” efficacy of CGRP monoclonal antibodies for migraine prevention: A meta-analysis of randomized controlled trials	13
Proposed general diagnostic criteria for secondary headaches	13
Bridging the gaps of headache care for underserved populations: Current status of the headache field in Latin America	13
Electrophysiological findings in migraine may reflect abnormal synaptic plasticity mechanisms: A narrative review	13
Prevalence and treatment of typical and atypical headaches in patients with Chiari I malformation: A meta-analysis and literature review	13
Hypnic Headache – What do we know in 2022?	13
Hypersensitivity to CGRP as a predictive biomarker of migraine prevention with erenumab	12
Cephalalgia: a legacy of excellence, a vision for tomorrow	12
Orofacial pain for clinicians: A review of constant and attack-like facial pain syndromes	12
Longitudinal differences in iron deposition in periaqueductal gray matter and anterior cingulate cortex are associated with response to erenumab in migraine	12
Prevalence of neck pain in migraine: A systematic review and meta-analysis	12
Late Breaking Author Index	12
What do people want to know about “Growing Up with Migraine”? Results of a preference survey of people with lived experience to guide future research	12
Activation of the trigeminal system as a likely target of SARS-CoV-2 may contribute to anosmia in COVID-19	12
Other primary headaches: Distinct clinical features and uncertain pathophysiology	12
Mutation screening and association analysis of NOTCH3 p.R544C in patients with migraine with or without aura	12
Smooth muscle ATP-sensitive potassium channels mediate migraine-relevant hypersensitivity in mouse models	12
Timing of headache after COVID-19 vaccines and its association with cerebrovascular events: An analysis of 41,700 VAERS reports	12
Erenumab versus topiramate for the prevention of migraine – a randomised, double-blind, active-controlled phase 4 trial	12
Open-label trials for CGRP-targeted drugs in migraine prevention: A narrative review	11
A need for an expert consensus guideline on performing peripheral nerve blocks in headache patients	11
The first prevalence study of primary headaches in adults in a post-conflict area of Serbia	11
Oxygen inhalation has no effect on provoked cranial autonomic symptoms using kinetic oscillation stimulation in healthy volunteers	11
Epicranial headaches part 2: Nummular headache and epicrania fugax	11
Response to letter to the Editor: Assessing migraine therapeutics	11
Comment on ‘'Correlation between endometriosis and migraine features: Results from a prospective case-control study'‘	11
An evolving machine-learning-based algorithm to early predict response to anti-CGRP monoclonal antibodies in patients with migraine	10
How migraine and its associated treatment impact on pregnancy outcomes: Umbrella review with updated systematic review and meta-analysis	10
Naratriptan is as effective as sumatriptan for the treatment of migraine attacks when used properly. A mini-review	10
Headache provocation by nitric oxide in men who have never experienced a headache	10
Persistent headache attributed to past cervicocephalic artery dissection: clinical characteristics and contributors to headache persistence	10
Migraine evolution after the cessation of CGRP(-receptor) antibody prophylaxis: a prospective, longitudinal cohort study	10
Impact on monthly migraine days of discontinuing anti-CGRP antibodies after one year of treatment – a real-life cohort study	10
Recovery and long-term outcome after neurosurgical closure of spinal CSF leaks in patients with spontaneous intracranial hypotension	10
Primary headache disorders in adolescents in North- and South-Tyrol: Findings of the EVA-Tyrol-Study	10
Treatment experiences and clinical characteristics in migraine and tension-type headache patients before the first visit to a tertiary headache center	10
Personal view: Modelling pain mechanisms of migraine without aura	10
Multidisciplinary headache treatment with work-focus in Norway: An observational study	10
Measuring headache day severity using multiple features in daily diary designs	10
Randomised, controlled trial of erenumab for the prevention of episodic migraine in patients from Asia, the Middle East, and Latin America: The EMPOwER study	10
Overuse of analgesics can affect the fertility biomarker Anti-Müllerian Hormone in females. A translational study	10
Safety and tolerability of fremanezumab in patients with episodic and chronic migraine: a pooled analysis of phase 3 studies	10
Developing an artificial intelligence-based headache diagnostic model and its utility for non-specialists’ diagnostic accuracy	10
Migraine and the risk of stroke in a middle-aged and elderly population: A prospective cohort study	10
Health care resource utilization and costs associated with diagnosed medication overuse headache and potential acute medication overuse in individuals with migraine	9
Open label experience of repeated OnabotulinumtoxinA injections towards the sphenopalatine ganglion in patients with chronic cluster headache and chronic migraine	9
Phenotyping non-idiopathic pseudotumor cerebri syndrome – A prospective cohort study	9
Non-invasive vagus nerve stimulation for prevention of migraine: The multicenter, randomized, double-blind, sham-controlled PREMIUM II trial	9
The influence of endogenous and exogenous hormonal factors on migraine in spontaneous postmenopausal women: A nationwide population-based study in South Korea	9
The evolutionary meaning of migraine	9
Update in the understanding of new daily persistent headache	9
The SIH-EBP Score: A grading scale to predict the response to the first epidural blood patch in spontaneous intracranial hypotension	9
Migraine and insufficient sleep: The effect of sleep restriction on nociceptive evoked potentials in migraine	9
A systematic evaluation of primary headache management apps leveraging behavior change techniques	9

E-diary use in clinical headache practice: A prospective observational study	9
Pathophysiology of cluster headache: From the trigeminovascular system to the cerebral networks	9
Lack of a direct link between macular cones function and photophobia in interictal migraine	9
Dysregulation of the peripheral glutamatergic system: A key player in migraine pathogenesis?	9
The characteristics of COVID-19 vaccine-related headache: Clues gathered from the healthcare personnel in the pandemic	9
Migraine and risk of hypertensive disorders of pregnancy: A population-based cohort study	9
It is a long way to the top if you wanna citations?	9
Investigations of the subarachnoid space as a potential link between aura and headache in migraine: A case-control MRI study	8
Pharmacologic characterization of atogepant: A potent and selective calcitonin gene–related peptide receptor antagonist	8
Functional magnetic resonance imaging in migraine: A systematic review	8
Medication “underuse” headache	8
Characteristics of pre-cluster symptoms in cluster headache: A cross-sectional multicentre study	8
Effectiveness of physiotherapy interventions on headache intensity, frequency, duration and quality of life of patients with tension-type headache. A systematic review and network meta-analysis	8
Prolonged headache with vaccine- and dose-specific headache pattern associated with vaccine against SARS-CoV-2 in patients with migraine	8
Visual snow syndrome is probably not mediated by CGRP: A case series	8
Aura in trigeminal autonomic cephalalgia is probably mediated by comorbid migraine with aura	8
NCOR2 is a novel candidate gene for migraine-epilepsy phenotype	8
Effect of KATP channel blocker glibenclamide on PACAP38-induced headache and hemodynamic	8
ANODYNE study: A double-blind randomized trial of greater occipital nerve block of methylprednisolone and lignocaine versus placebo as a transitional preventive treatment for episodic cluster headache	8
Identification of patients with chronic migraine by using sensory-evoked oscillations from the electroencephalogram classifier	8
The chicken and egg problem: CGRP release due to trigeminal activation or vice versa?	8
Effectiveness of anti-CGRP monoclonal antibodies on central symptoms of migraine	8
Update on cough, exertional and sex headache	8
Investigations of the migraine-provoking effect of levcromakalim in patients with migraine with aura	8
Bioequivalence of rimegepant, a small molecule CGRP receptor antagonist, administered as an oral tablet, a sublingual orally disintegrating tablet, and a supralingual orally disintegrating tablet: two	8
Diagnosis of idiopathic intracranial hypertension: A proposal for evidence-based diagnostic criteria	8
Corrigendum to: “CLOCK gene circannual expression in cluster headache”	8
Identification of brain areas in mice with peak neural activity across the acute and persistent phases of post-traumatic headache	8
The monoclonal CGRP-receptor blocking antibody erenumab has different effects on brainstem and cortical sensory-evoked responses	8
The prevalence of headache disorders in Postural Tachycardia Syndrome: A systematic review and meta-analysis of the literature	8
Transition of cluster headache phenotype: An interview-based study	8
FollowTheSutures: Piloting a new way to administer onabotulinumtoxinA for chronic migraine	8
Studying migraine as a risk factor for stroke: The importance of working with an explicit causal framework	8
A comparative study on prophylactic efficacy of cinnarizine and amitriptyline in childhood migraine: a randomized double-blind clinical trial	7
Calcitonin receptor antibody validation and expression in the rodent brain	7
Are PROMs passing the message? A reflection with real-life migraine patients	7
Functional brainstem representations of the human trigeminal cervical complex	7
Author Index	7
20th Congress of the International Headache Society September 8-12, 2021	7
Diagnosis, knowledge, perception, and productivity impact of headache education and clinical evaluation program in the workplace at an information technology company of more than 70,000 employees	7
Pharmacological modulation of ventral tegmental area neurons elicits changes in trigeminovascular sensory processing and is accompanied by glycemic changes: Implications for migraine	7
Clinical analysis of 30 cases of cardiac cephalalgia	7
What proportion of people with migraine report postdromal symptoms? A systematic review and meta-analysis of observational studies	7
Continuous positive airway pressure in cluster headache: A randomized, placebo-controlled, triple-blind, crossover study	7
Prevalence, clinical characteristics and associated factors of cardiac cephalalgia: A prospective study	7
Physical inactivity and headache disorders: Cross-sectional analysis in the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil)	7
Genome-wide association study reveals susceptibility loci for self-reported headache in a large community-based Asian population	7
Inhibiting PAC1 receptor internalization and endosomal ERK pathway activation may ameliorate hyperalgesia in a chronic migraine rat model	7
Enhanced audiovisual associative pair learning in migraine without aura in adult patients: An unexpected finding	7
Migraine and the development of additional psychiatric and pain disorders in the transition from adolescence to adulthood	7
Thanks to Reviewers	7
Methodology of drug trials in migraine: History and suggestions for the future	7
Preventive CGRP-targeted therapies for chronic migraine with and without medication-overuse headache	7
Minimal important difference of the Migraine Disability Assessment (MIDAS): Longitudinal data from the DMKG Headache Registry	7
No structural brain alterations in new daily persistent headache – a cross sectional VBM/SBM study	7
Building community and visibility: A year of social media growth for Cephalalgia	7
Epidemiology and clinical features of short-lasting unilateral neuralgiform headache attacks: A systematic review and meta-analysis	7
Time to retire ‘New daily persistent headache’: Mode of onset of chronic migraine and tension-type headache	6
A response: Update on cough, exertional and sex headache	6
The epidemiology of airplane headache: A cross-sectional study on point prevalence and characteristics in 50,000 travelers	6
Placebo and nocebo in the treatment of migraine: How much does real world effectiveness depend on contextual effects?	6
A male-specific mechanism of meningeal nociceptor sensitization promoting migraine headache	6
Identification and characterization of migraine in pregnancy: A Norwegian registry-based cohort study	6
What do patients’ efficacy and tolerability ratings of acute migraine medication tell us? Cross-sectional data from the DMKG Headache Registry	6
Pain in the temple? Headache, muscle pain or both: A retrospective analysis	6
CLOCK gene circannual expression in cluster headache	6
The effect of blood pressure lowering medications on the prevention of episodic migraine: A systematic review and meta-analysis	6
Response to letter to the editor: “What predicts citation counts and translational impact in headache research? A machine learning analysis”	6
Interim analysis of the Registry for Load and Management of Medication Overuse Headache (RELEASE): A multicenter, comprehensive medication overuse headache registry	6
Sex differences in effectiveness of CGRP receptor antagonism for treatment of acute and persistent headache-like pain in a mouse model of mild traumatic brain injury	6
DNA-methylation and immunological response in medication overuse headache	6
The role of cytokines in migraine: A systematic review	6
Indirect costs attributed to headache: A nation-wide survey of an active working population	6
The time sequence of brain MRI findings in spontaneous intracranial hypotension	6
New migraine drugs	6
Pediatric screen exposure and school related headache disability	6
Clarification on the incidence and sex-specificity of sexual dysfunction as an adverse event of CGRP-targeting medications	6
PACAP38- and VIP-induced cluster headache attacks are not associated with changes of plasma CGRP or markers of mast cell activation	6
Peripherally acting anti-CGRP monoclonal antibodies attenuate cortical resting-state connectivity in migraine patients	5
Thanks to Reviewers	5
Treatment pattern and response for cluster headache in Korea: A prospective multicenter observation study	5
New migraine prophylactic drugs: Current evidence and practical suggestions for non-responders to prior therapy	5
IHS Regional Headache Conference abstracts: 2022	5
Mechanisms of GTN-induced migraine: Role of NOS isoforms, sGC and peroxynitrite in a migraine relevant mouse model	5
Patterns of migraine medication use in Norway: A nationwide registry-based observational study	5
Effects of acupuncture and medical training therapy on depression, anxiety, and quality of life in patients with frequent tension-type headache: A randomized controlled study	5
The short-term effects of CGRP monoclonal antibodies on bone turnover: A prospective cohort study	5
COVID-19 vaccination elicited de novo and recurrence of cluster headache: A case series	5
Transorbital sonography: A non-invasive bedside screening tool for detection of pseudotumor cerebri syndrome	5
Perceived barriers to career progression in the headache field: A global web-based cross-sectional survey	5
Abstract Authors Index for MTIS 2022	5
Guidelines of the International Headache Society for Real-World Evidence studies in migraine and cluster headache	5
Migraine is the most disabling neurological disease among children and adolescents, and second after stroke among adults: A call to action	5
Increased prevalence of migraine in women with inflammatory bowel disease: A cross-sectional study	5
Identifying idiopathic intracranial hypertension in a hospital-based chronic headache population: Utility of magnetic resonance imaging, magnetic resonance venography and trans-orbital sonography	5